AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2048819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 7002706 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide (4.6 mg, 2.3 capsules)
Number of subjects: 30
Study 7002706 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (103.5 mg, 2.3 capsules)
Number of subjects: 30
Study 7002706 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenoxylate (12.5 mg, 2.5 capsules)
Number of subjects: 30
Study 7002706 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study 31998949 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface perturbation treadmill training integrated into usual multimodal exercise-based balance training
Number of subjects: 506
Study 31998949 — intervention group
Group type: COMPARATOR
Intervention: Usual multimodal exercise-based balance training alone
Number of subjects: 506
Study 31998949 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface perturbation treadmill training
Number of subjects: 506
Study 31839091 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (lactobacillus rhamnosus) with ORS
Number of subjects: 80
Study 31839091 — intervention group
Group type: COMPARATOR
Intervention: ORS only
Number of subjects: 80
Study 28746324 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 135
Study 28746324 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 135
Study 28746324 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (CBT and pharmacotherapy)
Number of subjects: 135
Study 25782662 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.375%
Number of subjects: 46
Study 25782662 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75%
Number of subjects: 46
Study 25782662 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.375% vs Ropivacaine 0.75%
Number of subjects: 46
Study 23894842 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical nursing pathway (CNP) group
Number of subjects: 64
Study 23894842 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing group (control group)
Number of subjects: 64
Study 21259026 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (A: 30 min, cycle ergometer, 75% of VO(2) peak)
Number of subjects: 20
Study 21259026 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (R: 6 exercises, 3 sets, 20 repetitions, 50% of 1 RM)
Number of subjects: 20
Study 21259026 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent exercise (AR: A + R)
Number of subjects: 20
Study 21259026 — intervention group
Group type: COMPARATOR
Intervention: Control (C: 30 min of rest)
Number of subjects: 20
Study 19275979 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet administration of the Kansas City Cardiomyopathy Questionnaire (KCCQ)
Number of subjects: 58
Study 19275979 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet administration of the Minnesota Living with Heart Failure Questionnaire (MLHFQ)
Number of subjects: 58
Study 19275979 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet administration of the Self-Care Heart Failure Index (SCHFI)
Number of subjects: 58
Study 19275979 — intervention group
Group type: COMPARATOR
Intervention: Pen-and-paper administration of the Kansas City Cardiomyopathy Questionnaire (KCCQ)
Number of subjects: 58
Study 19275979 — intervention group
Group type: COMPARATOR
Intervention: Pen-and-paper administration of the Minnesota Living with Heart Failure Questionnaire (MLHFQ)
Number of subjects: 58
Study 19275979 — intervention group
Group type: COMPARATOR
Intervention: Pen-and-paper administration of the Self-Care Heart Failure Index (SCHFI)
Number of subjects: 58
Study 17673936 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet
Number of subjects: 59
Study 17673936 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 59
Study 14767287 — intervention group
Group type: COMPARATOR
Intervention: EBRT alone (group 1)
Number of subjects: 481
Study 14767287 — intervention group
Group type: EXPERIMENTAL
Intervention: EBRT preceded by 3 months of AS (group 2)
Number of subjects: 481
Study 14767287 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant, concomitant and adjuvant AS for a total of 10 months (group 3)
Number of subjects: 481
Study 14767287 — intervention group
Group type: COMPARATOR
Intervention: Neoadjuvant and concomitant AS (total 5 months)
Number of subjects: 481
Study 14767287 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant, concomitant and short course adjuvant AS (total 10 months)
Number of subjects: 481
Study 11332151 — intervention group
Group type: EXPERIMENTAL
Intervention: CEF14 (chemotherapy regimen delivered every two weeks)
Number of subjects: 247
Study 11332151 — intervention group
Group type: COMPARATOR
Intervention: CEF21 (chemotherapy regimen delivered every three weeks)
Number of subjects: 247
Study 11332151 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionation (RT applied at 2.3 Gy per fraction)
Number of subjects: 247
Study 11332151 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant administration of RT and CT
Number of subjects: 247
Study 11332151 — intervention group
Group type: EXPERIMENTAL
Intervention: Age <= 55 years
Number of subjects: 247
Study 11332151 — intervention group
Group type: COMPARATOR
Intervention: Conventional RT
Number of subjects: 247
Study 11332151 — intervention group
Group type: COMPARATOR
Intervention: WBC toxicity (none)
Number of subjects: 247
Study 8995997 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral counseling to reduce ETS exposure
Number of subjects: 0
Study 8995997 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring control
Number of subjects: 0
Study 8995997 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care control
Number of subjects: 0
Study 8424300 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.3 mg orally)
Number of subjects: 60
Study 8424300 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine (1.5 mg.kg‐1 prior to induction)
Number of subjects: 60
Study 8424300 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention specified)
Number of subjects: 60
Study 3301160 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulatard
Number of subjects: 17
Study 3301160 — intervention group
Group type: COMPARATOR
Intervention: Lentard
Number of subjects: 17
Study 3301160 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixtard
Number of subjects: 17
Study 29334900 — intervention group
Group type: EXPERIMENTAL
Intervention: RaDIANT multicomponent education and quality improvement intervention
Number of subjects: 67
Study 29334900 — intervention group
Group type: EXPERIMENTAL
Intervention: RaDIANT intervention activities
Number of subjects: 67
Study 29334900 — intervention group
Group type: EXPERIMENTAL
Intervention: RaDIANT intervention components
Number of subjects: 67
Study 29334900 — intervention group
Group type: EXPERIMENTAL
Intervention: RaDIANT intervention
Number of subjects: 67
Study 28591942 — intervention group
Group type: EXPERIMENTAL
Intervention: Sialidase inhibitor N‐Acetyl‐2, 3‐dehydro‐2‐deoxyneuraminic acid (DANA)
Number of subjects: 0
Study 28591942 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 24491287 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral ileostomy
Number of subjects: 0
Study 24491287 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous ileostomy by exclusion probe
Number of subjects: 0
Study 22383336 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasireotide LAR 40 mg
Number of subjects: 12
Study 22383336 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasireotide LAR 60 mg
Number of subjects: 12
Study 22383336 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasireotide LAR (both doses)
Number of subjects: 12
Study 20542295 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri (DSM 17938)
Number of subjects: 44
Study 20542295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 18801190 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized hypnosis treatment with ten consecutive therapeutic sessions once a week, each lasting about 30 minutes, focusing on ego-strengthening, relaxation, releasing muscular tension, and increasing self-efficacy.
Number of subjects: 16
Study 18801190 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment during initial phase).
Number of subjects: 16
Study 15630590 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.65 g/kg alcohol
Number of subjects: 16
Study 15630590 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual degradation
Number of subjects: 16
Study 15630590 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol plus visual degradation
Number of subjects: 16
Study 15630590 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 16
Study 12717603 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous specific immunotherapy with Der p/Der f
Number of subjects: 13
Study 12717603 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 10493672 — intervention group
Group type: EXPERIMENTAL
Intervention: SLE sera absorbed with bacterial DNA
Number of subjects: 0
Study 10493672 — intervention group
Group type: EXPERIMENTAL
Intervention: NHS sera absorbed with bacterial DNA
Number of subjects: 0
Study 7600829 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiseptic hand washing with 4% chlorhexidine and alcohol
Number of subjects: 43
Study 7600829 — intervention group
Group type: COMPARATOR
Intervention: Casual donning of nonsterile gloves over unwashed hands
Number of subjects: 43
Study 7600829 — intervention group
Group type: COMPARATOR
Intervention: Casual donning of nonsterile gloves over washed hands
Number of subjects: 43
Study 7600829 — intervention group
Group type: COMPARATOR
Intervention: Aseptic donning technique with or without prior antiseptic hand washing
Number of subjects: 43
Study 2018441 — intervention group
Group type: EXPERIMENTAL
Intervention: Stanozolol 5 mg twice daily for 6 months
Number of subjects: 60
Study 2018441 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet twice daily for 6 months
Number of subjects: 60
Study 2018441 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Stanozolol and Placebo)
Number of subjects: 60
Study 2018441 — intervention group
Group type: EXPERIMENTAL
Intervention: Stanozolol
Number of subjects: 60
Study 7114130 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone implants (6 pellets of 100 mg each)
Number of subjects: 84
Study 7114130 — intervention group
Group type: COMPARATOR
Intervention: Injectable placebo
Number of subjects: 84
Study 7114130 — intervention group
Group type: COMPARATOR
Intervention: TCu 200 intrauterine contraceptive device
Number of subjects: 84
Study 31680183 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (horizontal placement on suprahyoid and infrahyoid muscles)
Number of subjects: 31
Study 31680183 — intervention group
Group type: COMPARATOR
Intervention: Group B (horizontal on suprahyoid, vertical on infrahyoid)
Number of subjects: 31
Study 31680183 — intervention group
Group type: COMPARATOR
Intervention: Group C (vertical placement above hyoid and cricoid)
Number of subjects: 31
Study 30531440 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife-based counseling education program (4 sessions, 70 minutes each, at 10-day intervals)
Number of subjects: 52
Study 30531440 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 52
Study 28237126 — intervention group
Group type: EXPERIMENTAL
Intervention: White matter lesions (WMLs) present
Number of subjects: 262
Study 28237126 — intervention group
Group type: COMPARATOR
Intervention: No white matter lesions (WMLs)
Number of subjects: 262
Study 26088940 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Pain Management Program (8-week online intervention)
Number of subjects: 92
Study 26088940 — intervention group
Group type: COMPARATOR
Intervention: Wait-list comparison (8-week delay)
Number of subjects: 92
Study 24706589 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 0
Study 22559239 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic LLS
Number of subjects: 110
Study 22559239 — intervention group
Group type: COMPARATOR
Intervention: Open LLS
Number of subjects: 110
Study 19603240 — intervention group
Group type: EXPERIMENTAL
Intervention: GEB-guided technique
Number of subjects: 75
Study 19603240 — intervention group
Group type: COMPARATOR
Intervention: IT-guided technique
Number of subjects: 75
Study 17304123 — intervention group
Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 32
Study 17304123 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 32
Study 17304123 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting extended position
Number of subjects: 32
Study 17304123 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine to standing position change
Number of subjects: 32
Study 17304123 — intervention group
Group type: EXPERIMENTAL
Intervention: L5/S1 level
Number of subjects: 32
Study 15385363 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 32
Study 15385363 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 32
Study 11419556 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 37
Study 11419556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 9738562 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltitrexed (3 mg/m2) once every 3 weeks
Number of subjects: 495
Study 9738562 — intervention group
Group type: COMPARATOR
Intervention: 5-FU (400 mg/m2) plus LV (200 mg/m2) daily for 5 days every 4 weeks
Number of subjects: 495
Study 7972979 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg b.i.d. (sustained release tablets)
Number of subjects: 153
Study 7972979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 7972979 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 153
Study 2743632 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily observed prophylaxis (DOP) and education
Number of subjects: 42
Study 2743632 — intervention group
Group type: COMPARATOR
Intervention: Self‐administered anti‐tuberculous prophylaxis (SAP) and education
Number of subjects: 42
Study 4851604 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride 10 mg daily in the postoperative period
Number of subjects: 0
Study 4851604 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31755620 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Maxillary Expansion (RME)
Number of subjects: 29
Study 31755620 — intervention group
Group type: COMPARATOR
Intervention: Slow Maxillary Expansion (SME)
Number of subjects: 29
Study 29459184 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary cadmium at 10 years (highest tertile: 0.30-2.6 μg/L)
Number of subjects: 1498
Study 29459184 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary cadmium at 5 years
Number of subjects: 1498
Study 29459184 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary cadmium at 10 years (highest tertile)
Number of subjects: 1498
Study 29459184 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal cadmium exposure
Number of subjects: 1498
Study 27116347 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel leg curl
Number of subjects: 36
Study 27116347 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic hamstring
Number of subjects: 36
Study 27116347 — intervention group
Group type: EXPERIMENTAL
Intervention: Russian belt
Number of subjects: 36
Study 27116347 — intervention group
Group type: EXPERIMENTAL
Intervention: Conic‐pulley exercise
Number of subjects: 36
Study 25400467 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle‐free incision suture closure
Number of subjects: 223
Study 25400467 — intervention group
Group type: COMPARATOR
Intervention: Butterfly bandage
Number of subjects: 223
Study 25400467 — intervention group
Group type: COMPARATOR
Intervention: Traditional secondary suturing technique
Number of subjects: 223
Study 22698919 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 pmol/kg/min human BNP-32 administered as a continuous infusion during 4 h
Number of subjects: 10
Study 22698919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 20555287 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (60 women)
Number of subjects: 121
Study 20555287 — intervention group
Group type: COMPARATOR
Intervention: Control group (61 women)
Number of subjects: 121
Study 18662627 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track group (FTG) with remifentanil and spinal analgesia (low-dose morphine and clonidine)
Number of subjects: 83
Study 18662627 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with sufentanil without spinal analgesia
Number of subjects: 83
Study 16649874 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco use intervention (smoking cessation, smokeless tobacco use cessation, or prevention)
Number of subjects: 33215
Study 16649874 — intervention group
Group type: COMPARATOR
Intervention: Health education control condition
Number of subjects: 33215
Study 16649874 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking prevention program
Number of subjects: 33215
Study 12514274 — intervention group
Group type: EXPERIMENTAL
Intervention: Pork meat cooked at 70 degrees C
Number of subjects: 21
Study 12514274 — intervention group
Group type: EXPERIMENTAL
Intervention: Pork meat cooked at 95 degrees C
Number of subjects: 21
Study 12514274 — intervention group
Group type: EXPERIMENTAL
Intervention: Pork meat cooked at 120 degrees C
Number of subjects: 21
Study 11225941 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractally coated electrode (iridium)
Number of subjects: 30
Study 11225941 — intervention group
Group type: COMPARATOR
Intervention: Uncoated electrode
Number of subjects: 30
Study 8727433 — intervention group
Group type: EXPERIMENTAL
Intervention: CT management (G1)
Number of subjects: 103
Study 8727433 — intervention group
Group type: COMPARATOR
Intervention: BP management (G2)
Number of subjects: 103
Study 1869800 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 mg aspirin per day for two days
Number of subjects: 70
Study 1869800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 6626478 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 ppm toluene for 6.5 hours
Number of subjects: 42
Study 6626478 — intervention group
Group type: COMPARATOR
Intervention: 0 ppm toluene for 6.5 hours
Number of subjects: 42
Study 6626478 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardisation of HA and O‐Cr concentrations
Number of subjects: 42
Study 30204520 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training and change‐of‐direction (COD) exercises
Number of subjects: 31
Study 30204520 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 31
Study 30204520 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training and COD exercises
Number of subjects: 31
Study 29183698 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized porous titanium implants
Number of subjects: 10
Study 29183698 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized PEEK implants
Number of subjects: 10
Study 26948292 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 44
Study 26948292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 24566753 — intervention group
Group type: EXPERIMENTAL
Intervention: High-repetition resistance training (3 d·wk for 6 months)
Number of subjects: 74
Study 24566753 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 74
Study 23106962 — intervention group
Group type: EXPERIMENTAL
Intervention: Criterion-based clinical audit (CBCA) applied by auditors at 8 sites in Mali and Senegal
Number of subjects: 818
Study 23106962 — intervention group
Group type: EXPERIMENTAL
Intervention: Criterion-based clinical audit (CBCA) conducted at 32 hospitals
Number of subjects: 818
Study 23106962 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted CBCA scores
Number of subjects: 818
Study 20166160 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL) treatment on one side of the face, four treatments at 3- to 4-week intervals.
Number of subjects: 24
Study 20166160 — intervention group
Group type: COMPARATOR
Intervention: Control side (untreated side of the face).
Number of subjects: 24
Study 17170356 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid Stenosis Index (CSI) estimate of carotid bulb size
Number of subjects: 268
Study 17170356 — intervention group
Group type: COMPARATOR
Intervention: Actual carotid bulb measurement
Number of subjects: 268
Study 16314784 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus plus low-dose short-term steroids
Number of subjects: 40
Study 11923325 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of ramoplanin
Number of subjects: 3
Study 11923325 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg of ramoplanin
Number of subjects: 3
Study 11923325 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 11923325 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramoplanin (all doses)
Number of subjects: 3
Study 11923325 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramoplanin (all doses) with antibiotics against anaerobic organisms
Number of subjects: 3
Study 11923325 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramoplanin (all doses) avoiding antibiotics against anaerobic organisms
Number of subjects: 3
Study 12712699 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy breakfast
Number of subjects: 151
Study 12712699 — intervention group
Group type: COMPARATOR
Intervention: Low energy breakfast
Number of subjects: 151
Study 8778647 — intervention group
Group type: EXPERIMENTAL
Intervention: EHDP (etidronate disodium)
Number of subjects: 77
Study 8778647 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated group)
Number of subjects: 77
Study 1977079 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-treatment group (zidovudine 250 mg every four hours)
Number of subjects: 524